• SBC Medical Group Holdings posted 2Q26 revenue of USD 49 million, up 13% year-over-year.
• Net income attributable to shareholders climbed to USD 11 million; net margin widened to 22% from 6%.
• Basic EPS rose to USD 0.10 from USD 0.02.
• Non-GAAP adjusted EBITDA increased to USD 20 million; margin improved to 41% from 35%.
• Growth drivers cited included points-business expansion, higher service fees from AI-enabled support, and a network of 287 locations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813064564) on August 13, 2026, and is solely responsible for the information contained therein.